New Model for Classifying Cancer Patients Could Lead to Better End-of-Life Care
Harvard Medical School researchers found Medicare’s policies governing cancer patient’s end-of-life care are based on generalized statistics often fail to
Read MoreHarvard Medical School researchers found Medicare’s policies governing cancer patient’s end-of-life care are based on generalized statistics often fail to
Read MorePrompted by a Justice Department announcement in June that Genesis Healthcare would pay the federal government more than $53.6 million
Read More(By Max Blau for ST A T) ATLANTA — The yellow pills had already killed four before landing in Brian
Read MoreAmgen Inc. and Teva Pharmaceutical Industries have raised the price of their cancer drugs (Blincyto and Treanda, respectively) last week
Read MoreArgus II Can Now Be Covered in Seven of 12 Medicare Administrative Contractor Jurisdictions, representing a total of 28 states,
Read More(By Fred Schulte for NPR) When Sol Shipotow enrolled in a new Medicare Advantage health plan earlier this year, he
Read More23andMe, the first company to win approval from the FDA to sell “direct to consumer” genetic test for five diseases
Read MoreAccording to Colonial Life’s white paper, “Big Picture Benefits: Looking past health care reform to a stronger benefits program,” found
Read More(By Morgan Haefner for Becker’s Hospital Review) Minnetonka, Minn.-based UnitedHealthcare will invest $18.3 million in two affordable housing complexes in
Read MorePolicy makers have been looking at how and where Medicare can be modernized, but they have overlooked the most obvious:
Read More